eprobemide

Uses your system voice; voice and rate in settings.

Q4086013Snapshot

≈ 1 min read

Names in other languages

  • Englisheprobemide
  • Tiếng ViệtEprobemide
  • فارسیاپروبماید
  • СрпскиEprobemid
  • 日本語エプロベミド
  • РусскийБефол

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Eprobemide (INN) is a pharmaceutical drug that was used as an antidepressant in Russia (under the brand name Бефол/Befol). It is a non-competitive reversible inhibitor of monoamine oxidase A that exhibits selective action on serotonin deamination. Eprobemide differs from moclobemide only in the linker that connects the morpholine fragment with the chlorobenzamide — moclobemide has two carbon atoms while eprobemide has three. Its registration was cancelled on December 30, 2003.

Eprobemide (INN) is a pharmaceutical drug that was used as an antidepressant in Russia (under the brand name Бефол/Befol). It is a non-competitive reversible inhibitor of monoamine oxidase A that exhibits selective action on serotonin deamination. Eprobemide differs from moclobemide only in the linker that connects the morpholine fragment with the chlorobenzamide — moclobemide has two carbon atoms while eprobemide has three. Its registration was cancelled on December 30, 2003.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1328676832 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.